THORNBURG INVESTMENT MANAGEMENT INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
THORNBURG INVESTMENT MANAGEMENT INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$755
+0.9%
7,4120.0%0.01%0.0%
Q2 2023$748
+9.7%
7,4120.0%0.01%
+9.1%
Q1 2023$682
+21.8%
7,412
+20.1%
0.01%
+22.2%
Q4 2022$560
-99.9%
6,1720.0%0.01%
+12.5%
Q3 2022$469,000
-10.2%
6,1720.0%0.01%0.0%
Q2 2022$522,000
-11.5%
6,172
-8.2%
0.01%0.0%
Q1 2022$590,000
-36.4%
6,722
-36.6%
0.01%
-27.3%
Q4 2021$927,000
+21.0%
10,595
+13.1%
0.01%
+22.2%
Q3 2021$766,000
-10.4%
9,3700.0%0.01%
-10.0%
Q2 2021$855,000
+6.7%
9,3700.0%0.01%
+11.1%
Q1 2021$801,000
-9.5%
9,3700.0%0.01%
-18.2%
Q4 2020$885,000
+8.6%
9,3700.0%0.01%0.0%
Q3 2020$815,000
-0.4%
9,3700.0%0.01%0.0%
Q2 2020$818,000
+5.8%
9,3700.0%0.01%0.0%
Q1 2020$773,000
-95.1%
9,370
-94.5%
0.01%
-92.7%
Q2 2019$15,672,000
-43.3%
171,638
-40.3%
0.15%
-43.8%
Q1 2019$27,648,000
-9.2%
287,584
-19.0%
0.27%
-10.4%
Q4 2018$30,462,000
+1.0%
354,988
+1.4%
0.30%
+18.3%
Q3 2018$30,167,000
+14.1%
350,122
-0.0%
0.25%
+25.4%
Q2 2018$26,449,000
+15.5%
350,133
+23.7%
0.20%
+16.2%
Q1 2018$22,890,000
+1.2%
283,123
+5.1%
0.17%
+10.2%
Q4 2017$22,616,000
-0.1%
269,363
+2.1%
0.16%
-3.1%
Q3 2017$22,638,000
+23.5%
263,694
+20.1%
0.16%
+16.5%
Q2 2017$18,334,000
-55.9%
219,647
-60.8%
0.14%
-58.9%
Q1 2017$41,608,000
+2.6%
560,224
+0.6%
0.34%
+8.0%
Q4 2016$40,554,000
+12.2%
556,755
+21.6%
0.31%
+13.8%
Q3 2016$36,160,000
-11.0%
457,951
-7.0%
0.28%
-12.7%
Q2 2016$40,642,000
+9.0%
492,566
-4.3%
0.32%
+26.5%
Q1 2016$37,280,000
+32.7%
514,633
+57.6%
0.25%
+39.1%
Q4 2015$28,104,000
-16.1%
326,643
-10.3%
0.18%
-14.8%
Q3 2015$33,484,000
+46.6%
364,279
+56.8%
0.21%
+59.1%
Q2 2015$22,843,000
-11.8%
232,287
-11.5%
0.13%
-8.3%
Q1 2015$25,887,000
-59.9%
262,518
-62.3%
0.14%
-55.4%
Q4 2014$64,549,000
-41.8%
696,618
-40.9%
0.32%
-35.5%
Q3 2014$110,971,000
-23.1%
1,178,916
-26.0%
0.50%
-12.9%
Q2 2014$144,227,000
+23.5%
1,593,145
+16.0%
0.58%
+25.0%
Q1 2014$116,788,000
-8.0%
1,373,651
-13.0%
0.46%
-5.2%
Q4 2013$126,969,000
-16.1%
1,579,613
-19.9%
0.48%
-20.5%
Q3 2013$151,344,000
+10.1%
1,972,941
+1.5%
0.61%
-2.7%
Q2 2013$137,510,0001,944,7050.63%
Other shareholders
NOVARTIS A G shareholders Q3 2022
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders